$ALXO Cashflow Statement | Understand Stock

$ALXO

$1.13 -$0.04 (3.42%) Close

$ALXO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Non-cash lease costs
Acquired in-process research and development
Net accretion of discounts on investments
Accretion of term loan discount and issuance costs
Impairment charge
Loss on disposal of fixed asset
Changes in operating assets and liabilities
Prepaid expenses and other current assets
Other assets
Accounts payable
Payable and accrued liabilities due to related party
Accrued expenses and other current liabilities
Other non-current liabilities

Net cash used in operating activities
Investing activities
Purchase of investments
Maturities of investments
Purchase of property and equipment
Acquisition of in-process research and development
Net cash provided by investing activities

Financing activities
Proceeds from equity offerings, net of underwriter discounts ($3,795 thousand) and issuance costs ($567 thousand)
Proceeds from ATM offering, net of commissions
Payments of offering costs
Proceeds from exercise of stock options under equity incentive plan
Proceeds from issuance of common stock under employee stock purchase plan
Principal payments on finance leases
Proceeds from issuance of term loan, net
Payments of debt issuance costs
Principal payments on term loan
Net cash provided by financing activities

Net (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure
Cash paid for interest
Cash paid for taxes

Supplemental disclosure of non-cash investing and financing activities
Purchase of property and equipment in accounts payable and accrued expenses
Acquisition of in-process research and development in accounts payable and accrued expenses
Right-of-use asset acquired under finance leases
Right-of-use asset acquired under operating leases
Right-of-use asset (modified) acquired under finance leases

Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash (included in other assets)

Comments